A Bad Fit: Dan Leonard’s Leadership Style Did Not Translate At Generics Group
Executive Summary
Former employees at the Association for Accessible Medicines detail problems that emerged during Leonard’s tenure, but also say the board of directors must improve its management of the trade organization.
You may also be interested in...
Former AAM Boss Leonard Moves To Brand Drug Industry-Backed We Work For Health
The 16-year-old WWFH is closely aligned with PhRMA and focuses on ‘bringing together national and local business leaders, labor, biopharma, patient advocacy and other healthcare-related stakeholders.’
Supplemental Filings: Pink Sheet Notebook On Disease Lobbying, Dan Leonard’s Next Act, And More
Quick takes on Ultragenyx’s CEO lobbing the US FDA for rare disease policy changes, the agency naming a new deputy assistant commissioner for media affairs, the former CEO of AAM starting a consulting firm, and more.
Teva Quits PhRMA As Financial, Policy Challenges Loom For The Brand/Generic Hybrid Giant
With a leadership position in the US generics association and a new CEO focused on how to reallocate resources, Teva leaves the brand trade association after a review of the ‘effectiveness and value of engagements.’